Diabetic Foot Ulcers Treatment Market Size, Share and Trends Analysis by Region, Treatment (Biologics, Wound Care Dressings, Therapy Devices, and Others), Ulcers Type (Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers), End-user (Homecare Settings, Hospitals and Specialty Clinics, Others) and Segment Forecast, 2022-2027

Pages: 102 Published: November 22, 2022 Report Code: GDPH-SC-MR008

The diabetic foot ulcers market size was valued at US$ 4.74 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% during 2022-2027. The key to the growth has been the rising prevalence of diabetes and resulting increase in incidence of diabetic foot ulcers. Additionally, rise in geriatric population, and increasing adoption of novel biologics and wound care devices for treatment, favoring diabetic foot ulcers market growth.

Diabetic Foot Ulcers Market Overview

Diabetic Foot Ulcers Market Overview

View Sample Report for Additional Insights on the Diabetic Foot Ulcers Market Forecast, Download a Free Report Sample

Diabetic Foot Ulcers Market Segmentation by Treatment

There are four major treatment approaches – Biologics, Wound Care Dressings, Therapy Devices, and Others

In 2021, biologics captured a sizeable market share exceeding 30% worldwide. The growth of the biologics is driven by factors such as new product launches and growing adoption of biologics drugs for diabetic foot ulcers. Biologics treatment for diabetic foot ulcers comprises growth factors, like Platelet-Derived Growth Factor (PDGF), Vascular Endothelial Growth Factor (VEGF), stem cells, and other anti-diabetic drugs. These agents help in reducing hyperglycemia, improve oxygenation & circulation, and restore lost tissues. Thus, they are mainly being adopted for wound management in different phases and are ideal for diabetic foot ulcer treatment. Currently, Regranex (becaplermin) marketed by Smith & Nephew is the only FDA-approved PDGF for the treatment of diabetic neuropathic ulcers, designed to act as a first-line treatment following effective ulcer care.

Diabetic Foot Ulcers Market Share by Treatment, 2021 (%)

Diabetic Foot Ulcers Market Share by Treatment, 2021 (%)

Fetch Sample PDF for Segment-Specific Revenues and Shares, Download a Free Report Sample

Diabetic Foot Ulcers Market Segmentation by Ulcers Type

The diabetic foot ulcers market can be segmented into neuro-ischemic ulcers, neuropathic ulcers, and ischemic ulcers, based on ulcer type. The neuro-ischemic ulcers segment contributed a significant revenue-generating US$ 1.79 billion in 2021. The segment is projected to grow at a CAGR of 8.0% to reach US$ 2.81 billion by 2027 . The variety of risks connected to neuro-ischemic ulcers, including infection, amputation, and mortality, can be attributed for the segment’s expansion.

Diabetic Foot Ulcers Market Share by Ulcers Type, 2021 (%)

Diabetic Foot Ulcers Market Share by Ulcers Type, 2021 (%)

Fetch Sample PDF for Segment-Specific Revenues and Shares, Download a Free Report Sample

Diabetic Foot Ulcers Market Analysis by End-User

The diabetic foot ulcers market can be segmented into homecare settings, hospitals & specialty clinics, and others, based on end-user. The homecare settings segment contributed a significant revenue-generating US$ 2.18 billion in 2021. The segment is projected to grow at a CAGR of 7.5% to reach US$ 3.31 billion by 2027. Home-based interventions are crucial in enhancing patient and family self-care management for aged patients and those with diabetic foot ulcers-related mobility limitation. Families can be strengthened by participation in each intervention, which can aid patients with monitoring.

Diabetic Foot Ulcers Market Share by End-user, 2021 (%)

Diabetic Foot Ulcers Market Share by End-user, 2021 (%)

Fetch Sample PDF for Segment-Specific Revenues and Shares, Download a Free Report Sample

Diabetic Foot Ulcers Market Analysis by Region

The diabetic foot ulcers market in North America was valued at US$ 2.02 billion in 2021 North America accounted for the largest share of the total diabetic foot ulcers opportunity in 2021. North America is projected to dominate the diabetic foot ulcers market during the forecast period, owing to the presence of strong healthcare infrastructure, high adoption of latest and branded products, well-established reimbursement policies, and increasing prevalence of the diabetes leading to diabetes foot ulcers.

Diabetic Foot Ulcers Market Share by Region, 2021 (%)

Diabetic Foot Ulcers Market Share by Region, 2021 (%)

View Sample Report for Additional Diabetic Foot Ulcers Market Insights, Download a Free Report Sample

Diabetic Foot Ulcers Market – Competitive Landscape

The diabetic foot ulcers market has a highly competitive landscape. It is led by leading players such as Smith & Nephew Plc and Coloplast A/S. Diabetic foot ulcers is a growing market with an impressive pipeline of new products. Key players operating in the diabetic foot ulcers market are more focused on organic growth strategies, especially innovative product development and expansion, to launch more advanced diabetic foot ulcers treatment and management products in order to cater to the mounting demand. For instance, in November 2022, Advanced Oxygen Therapy, Inc., an US-based manufacturer of wound healing products, received approval for its novel cyclically pressurized Topical Wound Oxygen (TWO2) therapy from Chinese National Medical Products Administration (NMPA).

Leading Players in the Diabetic Foot Ulcers Market

  • Smith & Nephew Plc
  • Coloplast A/S
  • ConvaTec Group Plc
  • Organogenesis Holdings Inc.
  • Paracrine Inc.
  • Alkem Laboratories Ltd.
  • Braun Melsungen AG
  • Molnlycke Health Care AB
  • 3M Health Care
  • Medline Industries Inc.

Other Diabetic Foot Ulcers Market Vendors Mentioned

Centaur Pharmaceuticals Pvt. Ltd., Tissue Regenix Group Plc, Integra Lifesciences Holdings Corp., Cardinal Health, Inc.

To Know More About Leading Diabetic Foot Ulcers Market Players, Download a Free Report Sample

Diabetic Foot Ulcers Market Research Overview

Market Size (2021) US$ 4.74 billion
Market Size (2027) US$ 7.03 billion
CAGR 7.1%
Forecast Period 2022-2027
Historic Period 2020-2021
Report Scope & Coverage Revenue Forecast, Segmental Market Share, Growth Trends
Treatment Segment Biologics, Wound Care Dressings, Therapy Devices, and Others
Ulcer Type Segment Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers
End-user Segment Homecare settings, Hospitals & Specialty Clinics, and Others
Key Companies Smith & Nephew Plc, Coloplast A/S, ConvaTec Group Plc, Organogenesis Holdings Inc., Paracrine, Inc., Alkem Laboratories Ltd., B. Braun Melsungen AG, Molnlycke Health Care AB, 3M Health Care, Medline Industries Inc.

Diabetic Foot Ulcers Market Scope

GlobalData Plc has segmented the diabetic foot ulcers market report by treatment, ulcers type, end-user, and region:

Diabetic Foot Ulcers, by Treatment Outlook (Revenue, USD Million, 2020-2027)

  • Biologics
  • Wound Care Dressings
  • Therapy Devices
  • Others 

Diabetic Foot Ulcers, by Ulcers Type Outlook (Revenue, USD Million, 2020-2027)

  • Neuro-ischemic Ulcers
  • Neuropathic Ulcers
  • Ischemic Ulcers

Diabetic Foot Ulcers, by End-user Outlook (Revenue, USD Million, 2020-2027)

  • Homecare settings
  • Hospitals and Specialty Clinics
  • Others

Diabetic Foot Ulcers Regional Outlook (Revenue, USD Million, 2020-2027)

  • North America
  • US
  • Canada
  • Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific 
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • ROW

The market intelligence report provides an in-depth analysis of the following –

  • Diabetic foot ulcers market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the treatment, ulcer type, and end-user segments.
  • The competitive landscape: an examination of the positioning of leading players in the diabetic foot ulcers market.
  • Company snapshots: analysis of the market position of leading players in the diabetic foot ulcers market.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global diabetic foot ulcers market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in diabetic foot ulcers markets.
  • The report also highlights key treatment, ulcer type, and end-user.
  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in diabetic foot ulcers markets.

Key Players

Smith & Nephew Plc
Coloplast A/S
ConvaTec Group Plc
Organogenesis Holdings Inc.
Paracrine Inc.
Alkem Laboratories Ltd.
B. Braun Melsungen AG
Molnlycke Health Care AB
3M Health Care
Medline Industries Inc.

Table of Contents

CHAPTER 01 Executive Summary

1.1 Diabetic Foot Ulcers Market Snapshot

Fig.1 Market Snapshot (US$ Mn)

1.2 Diabetic Foot Ulcers Market- Key Findings

Fig.2 Key Segment Performance Snapshot

CHAPTER 02 Market Landscape

2.1 Market Definition

2.2 Market Scope and Segmentation

CHAPTER 03 Diabetic Foot Ulcers – Market Dynamics

3.1 Diabetic Foot Ulcers – Epidemiology

3.1.1 Risk Factors and Comorbidities

3.2 Diabetic Foot Ulcers – Therapeutic Development

3.2.1 Pipeline Overview

Fig.3 Number of Products under Development for Diabetic Foot Ulcers, 2021

3.2.2 Pipeline by Companies, 2021

3.2.3 Products under Development by Companies, 2021

3.2.4 Number of Products by Stage and Route of Administration, 2021

3.2.5 Number of Products by Molecule Type, 2021

3.3 Diabetic Foot Ulcers – Product Development Milestones

3.4 Diabetic Foot Ulcers – Trends, Drivers, and Challenges

3.4.1 Diabetic Foot Ulcers – Market Trends

3.4.2 Diabetic Foot Ulcers – Market Drivers

3.4.3 Diabetic Foot Ulcers – Market Challenges

3.5 Diabetic Foot Ulcers Market Structure – PORTER’s Analysis

Fig.4 Global Diabetic Foot Ulcers PORTER’s Five Force Analysis

3.6 Diabetic Foot Ulcers – Impact of COVID-19

3.7 Diabetic Foot Ulcers – Regulatory Scenario

3.7.1 Regulation for Medical Devices

3.7.2 Regulations for Biopharmaceuticals

CHAPTER 04 Global Diabetic Foot Ulcers Revenue Opportunity

4.1 Global Diabetic Foot Ulcers Market

Fig.5 Global Diabetic Foot Ulcers Market – Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

CHAPTER 05 Diabetic Foot Ulcers Type Outlook

5.1 Diabetic Foot Ulcers – Ulcers Type Deep Dive

Fig.6 Diabetic Foot Ulcers by Ulcers Type – Market Overview (US$ Mn)

Fig.7 Diabetic Foot Ulcers by Ulcers Type Share – 2021 & 2027 (%)

5.1.1 Neuro-Ischemic Ulcers

Fig.8 Neuro-Ischemic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

5.1.2 Neuropathic Ulcers

Fig.9 Neuropathic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

5.1.3 Ischemic Ulcers

Fig.10 Ischemic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

CHAPTER 06 Diabetic Foot Ulcers Treatment Outlook

6.1 Diabetic Foot Ulcers – Treatment Deep Dive

Fig.11 Diabetic Foot Ulcers by Treatment – Market Overview (US$ Mn)

Fig.12 Diabetic Foot Ulcers by Treatment Share – 2021 & 2027 (%)

6.1.1 Biologics

Fig.13 Biologics Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

6.1.2 Wound Care Dressings

Fig.14 Wound Care Dressings Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

6.1.3 Therapy Devices

Fig.15 Therapy Devices Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

6.1.4 Others

Fig.16 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

CHAPTER 07 Diabetic Foot Ulcers End User Outlook

7.1 Diabetic Foot Ulcers – End User Deep Dive

Fig.17 Diabetic Foot Ulcers by End User – Market Overview (US$ Mn)

Fig.18 Diabetic Foot Ulcers by End User Share – 2021 & 2027 (%)

7.1.1 Homecare Settings

Fig.19 Homecare Settings Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

7.1.2 Hospitals and Specialty Clinics

Fig.20 Hospitals and Specialty Clinics Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

7.1.3 Others

Fig.21 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

CHAPTER 08 Diabetic Foot Ulcers by Regional Outlook

8.1 Diabetic Foot Ulcers – Regional Deep Dive

Fig.22 Diabetic Foot Ulcers by Region – Market Overview (US$ Mn)

Fig.23 Diabetic Foot Ulcers by Region Share – 2021 & 2027 (%)

8.1.1 North America

Fig.24 North America Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

8.1.2 Europe

Fig.25 Europe Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

8.1.3 Asia-Pacific

Fig.26 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

8.1.4 ROW

Fig.27 ROW Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

CHAPTER 09 Diabetic Foot Ulcers – Competitive Landscape

9.1.1 Heat Map Analysis

9.1.2 Key Players strategy Outlook

9.1.3 Recent Product Launches & approvals

9.1.4 Recent partnerships, alliances, collaborations

CHAPTER 010 Diabetic Foot Ulcers Vendor Snapshot

10.1.1 Company snapshot: Smith & Nephew plc

10.1.2 Company snapshot: Convatec Group plc

10.1.3 Company snapshot: Organogenesis, Inc.

10.1.4 Company snapshot: Paracrine, Inc.

10.1.5 Company snapshot: Alkem Laboratories Ltd.

10.1.6 Company snapshot: Coloplast A/S

10.1.7 Company snapshot: B. Braun Melsungen AG

10.1.8 Company snapshot: Molnlycke Health Care AB

10.1.9 Company snapshot: Medline Industries, Inc.

10.1.10 Company snapshot: 3M Health Care

10.1.11 Centaur Pharmaceuticals Pvt. Ltd.

10.1.12 Tissue Regenix Group Plc

10.1.13 Integra LifeSciences Holdings Corp

10.1.14 Cardinal Health, Inc.

10.1.15 Podimetrics, Inc.

10.1.16 Destiny Pharma Plc

10.1.17 PolarityTE, Inc.

10.1.18 Cellresearch Corp Pte. Ltd.

10.1.19 Healthium Medtech Pvt. Ltd.

10.1.20 Recce Pharmaceuticals Ltd.

CHAPTER 011 Appendix

11.1 Methodology

11.2 About US

Contact Us

List of Tables

Table 1 Key Trends, Drivers, and Challenges Overview

Table 2 Research Scope and Segmentation

Table 3 Risk Factors and Comorbidities of Diabetic Foot Ulcers

Table 4 Number of Products under Development for Diabetic Foot Ulcers, 2021

Table 5 Pipeline by Companies for Diabetic Foot Ulcers, 2021

Table 6 Products under Development by Companies for Diabetic Foot Ulcers, 2021

Table 7 Products under Development by Route of Administration for Diabetic Foot Ulcers, 2021

Table 8 Products under Development by Molecule Type for Diabetic Foot Ulcers, 2021

Table 9 Global Diabetic Foot Ulcers Market

Table 10 Fig.7 Diabetic Foot Ulcers by Ulcers Type , 2020-2027 (US$ Mn)

Table 11 Fig.12 Diabetic Foot Ulcers by Treatment, 2020-2027 (US$ Mn)

Table 12 Fig.17 Diabetic Foot Ulcers by End User, 2020-2027 (US$ Mn)

Table 13 Diabetic Foot Ulcers by Region, 2020-2027 (US$ Mn)

Table 14 North America Diabetic Foot Ulcers by Country, 2020-2027 (US$ Mn)

Table 15 Europe Diabetic Foot Ulcers by Country, 2020-2027 (US$ Mn)

Table 16 Asia-Pacific Diabetic Foot Ulcers by Country, 2020-2027 (US$ Mn)

List of Figures

Fig.1 Market Snapshot (US$ Mn)

Fig.2 Key Segment Performance Snapshot

Fig.3 Number of Products under Development for Diabetic Foot Ulcers, 2021

Fig.4 Global Diabetic Foot Ulcers PORTER’s Five Force Analysis

Fig.5 Global Diabetic Foot Ulcers Market – Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.6 Diabetic Foot Ulcers by Ulcers Type – Market Overview (US$ Mn)

Fig.7 Diabetic Foot Ulcers by Ulcers Type Share – 2021 & 2027 (%)

Fig.8 Neuro-Ischemic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.9 Neuropathic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.10 Ischemic Ulcers Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.11 Diabetic Foot Ulcers by Treatment – Market Overview (US$ Mn)

Fig.12 Diabetic Foot Ulcers by Treatment Share – 2021 & 2027 (%)

Fig.13 Biologics Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.14 Wound Care Dressings Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.15 Therapy Devices Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.16 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.17 Diabetic Foot Ulcers by End User – Market Overview (US$ Mn)

Fig.18 Diabetic Foot Ulcers by End User Share – 2021 & 2027 (%)

Fig.19 Homecare Settings Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.20 Hospitals and Specialty Clinics Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.21 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.22 Diabetic Foot Ulcers by Region – Market Overview (US$ Mn)

Fig.23 Diabetic Foot Ulcers by Region Share – 2021 & 2027 (%)

Fig.24 North America Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.25 Europe Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.26 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.27 ROW Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Frequently Asked Questions

The diabetic foot ulcers size globally was valued at US$ 4.74 billion in 2021.

The diabetic foot ulcers market is expected to grow at a CAGR of 7.1% during the forecast period (2022-2027).

Rising prevalence of diabetes, rise in geriatric population, and increasing adoption of novel biologics and wound care devices for treatment are the key factors fueling diabetic foot ulcers market growth.

Treatment Segments: Biologics, Wound Care Dressings, Therapy Devices, and Others

Ulcer Type Segment: Neuro-ischemic Ulcers, Neuropathic Ulcers, and Ischemic Ulcers

End-user Segment: Homecare settings, Hospitals & Specialty Clinics, and Others

Some of the leading companies in the diabetic foot ulcers market are Smith & Nephew Plc, Coloplast A/S, ConvaTec Group Plc, Organogenesis Holdings Inc., Paracrine, Inc., among others

$3,950

Can be used by individual purchaser only

$7,950

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.